Abstract
Summary
Global Veterinary Vaccines Market Size, Share & Trends Analysis Report, By Product (Livestock Vaccines, Companion Animal Vaccines, Porcine Vaccines, Equine Vaccines, Poultry Vaccines, Aquaculture Vaccines, and Others), By Technology (Inactivated Vaccines, Live Attenuated Vaccines, Subunit Vaccines, Toxoid Vaccines, Recombinant Vaccines, DNA Vaccines, and Conjugate Vaccines), By Diseases (Poultry Diseases, Companion Animal Diseases, Livestock Diseases, Aquaculture Diseases, and Others), Forecast Period (2022-2028)
The global veterinary vaccines market is anticipated to grow at a CAGR of 9.2% during the forecast period. The increasing outbreak of cattle diseases and growing demand for animal treatment are some key factors driving the growth of the market. The rising incidence of zoonotic diseases, initiatives by various government agencies and animal associations to maintain animal health, and the rising demand for animal-derived food products are some factors contributing to the market growth.
The global veterinary vaccines market is segmented by product, technology, and diseases. The market segmentation based on the product includes livestock vaccines, companion animal vaccines, porcine vaccines, equine vaccines, poultry vaccines, aquaculture vaccines and others. Based on technology, the market is segmented into inactivated vaccines, live attenuated vaccines, subunit vaccines, toxoid vaccines, recombinant vaccines, DNA vaccines, and conjugate vaccines. Based on diseases, the market is segmented into poultry diseases, companion animal diseases, livestock diseases, aquaculture diseases, and others.
The global veterinary vaccines market is further segmented based on geography including North America (the US and Canada), Europe (UK, Italy, Spain, Germany, France, and Others), Asia-Pacific (India, China, Japan, South Korea, and Others), and the Rest of the World (the Middle East & Africa and Latin America). The market can be analyzed for a particular region or country level as per the requirement. In 2021, North America held a considerable share in the global veterinary vaccines market. The rising public-private funding and research grants for developing safe & effective veterinary vaccine products and the growing number of clinical trials across the US are key factors driving the growth of the veterinary vaccines market in the region.
The major companies serving the global veterinary vaccines market include Merck & Co. Inc., Zoetis Inc., Sanofi S.A., Boehringer Ingelheim International GmbH, and Ceva Sante Animale. The companies are focusing on product innovation, technology advancements, expansions, mergers and acquisitions, and finding a new market or innovation in their core competency to expand individual market share.
Research Methodology
The market study of the global veterinary vaccines market is incorporated by extensive primary and secondary research conducted by the research team at OMR. Secondary research has been conducted to refine the available data to break down the market into various segments, and derive the total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior, and macro-economic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives as possible, managers, key opinion leaders, and industry experts. Primary research brings authenticity to our reports.
Secondary Sources Include
• Financial reports of companies involved in the market.
• Whitepapers, research papers, and news blogs.
• Company websites and their product catalog.
The report provides an in-depth analysis of the market size, and intended quality of the service preferred by consumers. The report will serve as a source for a 360-degree analysis of the market thoroughly integrating different models.
Market Segmentation
1. Global Veterinary Vaccines Market Research and Analysis by Product
2. Global Veterinary Vaccines Market Research and Analysis by Technology
3. Global Veterinary Vaccines Market Research and Analysis by Disease
The Report Covers
• Comprehensive research methodology of the global veterinary vaccines market.
• This report also includes a detailed and extensive market overview with key analyst insights.
• An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
• Analysis of regional regulations and other government policies impacting the global veterinary vaccines market.
• Insights about market determinants that are stimulating the global veterinary vaccines market.
• Detailed and extensive market segments with the regional distribution of forecasted revenues.
• Extensive profiles and recent developments of market players.
Table of Contents
1 Report Summary
1.1 Research Methods and Tools
1.2 Market Breakdown
1.2.1 By Segments
1.2.2 By Region
2 Market Overview and Insights
2.1 Scope of the Report
2.2 Analyst Insight & Current Market Trends
2.2.1 Key Findings
2.2.2 Recommendations
2.2.3 Conclusion
3 Competitive Landscape
3.1 Key Company Analysis
3.1.1 Overview
3.1.2 Financial Analysis
3.1.3 SWOT Analysis
3.1.4 Recent Developments
3.2 Key Strategy Analysis
4 Market Segmentation
4.1 Global Veterinary Vaccines Market, By Product
4.1.1 Livestock Vaccines
4.1.2 Companion Animal Vaccines
4.1.3 Porcine Vaccines
4.1.4 Equine Vaccines
4.1.5 Poultry Vaccines
4.1.6 Aquaculture Vaccines
4.1.7 Others
4.2 Global Veterinary Vaccines Market, By Technology
4.2.1 Inactivated Vaccines
4.2.2 Live Attenuated Vaccines
4.2.3 Subunit Vaccines
4.2.4 Toxoid Vaccines
4.2.5 Recombinant Vaccines
4.2.6 DNA Vaccines
4.2.7 Conjugate Vaccines
4.3 Global Veterinary Vaccines Market, By Diseases
4.3.1 Poultry Diseases
4.3.2 Companion Animal Diseases
4.3.3 Livestock Diseases
4.3.4 Aquaculture Diseases
4.3.5 Others
5 Regional Analysis
5.1 North America
5.1.1 United States
5.1.2 Canada
5.2 Europe
5.2.1 UK
5.2.2 Germany
5.2.3 Italy
5.2.4 Spain
5.2.5 France
5.2.6 Rest of Europe
5.3 Asia-Pacific
5.3.1 China
5.3.2 India
5.3.3 Japan
5.3.4 South Korea
5.3.5 Rest of Asia-Pacific
5.4 Rest of the World
6 Company Profiles
6.1 Anicor Labor GmbH
6.2 Arko Laboratories, Inc
6.3 Biovac
6.4 Boehringer Ingelheim GmbH
6.5 Ceva Sante Animale
6.6 Colorado Serum Co
6.7 Hygieia Biological Laboratories
6.8 Merck & Co. Inc
6.9 Merial
6.10 Nexvet
6.11 Pfizer Inc
6.12 PHL Associates, Inc
6.13 Romvac
6.14 Sanofi SA
6.15 Vaxxinova
6.16 Zoetis Inc